Skip to main content
. 2014 Nov 20;16(1):88–96. doi: 10.4161/15384047.2014.987029

Figure 1.

Figure 1.

USP22 protein and mRNA expression in nasopharyngeal carcinoma tissues and non-cancerous nasopharyngeal mucosa. (A) The expression of USP22 in nasopharyngeal carcinoma tissue and non-cancerous nasopharyngeal mucosa via immunohistochemistry analysis. lefe pannel: non-cancerous nasopharyngeal mucosa; middle pannel: nasopharyngeal carcinoma tissues; right pannel: negative control without USP22 antibody. (B) USP22 mRNA expression in nasopharyngeal carcinoma tissue and non-cancerous nasopharyngeal mucosa via quantitative RT-PCR analysis. All experiments were performed in triplicate and results are expressed as means ± SD analyzed with t-test. **: P < 0.01.